ARCHIVES

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997

Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials.

February 25, 2000

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

In Brief: Georgetown Professor Heads Cancer Therapy Evaluation Program; NCI-VA Branch Abolished

September 7, 1979